Skip to main content

Table 3 Clinical parameters of headache and their impact on FGF-21 and GDF-15 levels in migraineurs. Partial correlation analysis was used for analysis. The results are given as r values (p values). The results are given as p values

From: FGF-21 and GDF-15 are increased in migraine and associated with the severity of migraine-related disability

Clinical parameters

FGF-21

GDF-15

age

0.285 (p < 0.001)

0.233 (p < 0.001)

BMI

0.075 (p = 0.254)

-0.083 (p = 0.204)

gender

0.088 (p = 0.179)

0.060 (p = 0.356)

monthly headache days

0.061 (p = 0.357)

0.017 (p = 0.799)

peak headache pain intensity (VAS)

-0.065 (p = 0.328)

0.096 (p = 0.146)

family history

-0.148 (p = 0.035)

-0.004 (p = 0.960)

migraine with aura

-0.007 (p = 0.918)

0.037 (p = 0.602)

nausea or vomit

-0.076 (p = 0.247)

-0.107 (p = 0.102)

vertigo

-0.022 (p = 0.756)

0.001 (p = 0.993)

photophobia and phonophobia

-0.005 (p = 0.938)

-0.111 (p = 0.112)

MOH

-0.037 (p = 0.623)

0.093 (p = 0.213)

menstrual migraine

-0.084 (p = 0.294)

0.041 (p = 0.609)

  1. MOH Medication-overuse headache, VAS Visual analogue scale